The role of drugs in a malaria program.
D000655:Amodiaquine / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use; D012008:Recurrence; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000962:Antimalarials; D013449:Sulfonamides; D013450:Sulfones; D000655:Amodiaquine; D002738:Chloroquine; D014295:Trimethoprim; D011796:Quinacrine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine